France· FR:60175716
IPRATROPIUM AGUETTANT ADULTES 0,5 mg/2 ml, solution pour inhalation par nébuliseur en récipient unidose
A medicinal product containing ipratropium (bromure d') monohydraté, registered in France by AGUETTANT, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- IPRATROPIUM (BROMURE D') MONOHYDRATÉ
- Manufacturer
- AGUETTANT
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip13340093658177710 récipient(s) unidose(s) polyéthylène de 2 mlEUR 3.74
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ipratropium (bromure d') monohydraté in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwedenAtrovent 0,25 mg/ml Lösning för nebulisatorAbacus Medicine A/S
- BelgiumAtrovent 0.5 mg/2 mlBoehringer Ingelheim
- NetherlandsAtrovent Unit Dose 500 microgram/2 ml, verneveloplossingBoehringer Ingelheim B.V.
- IrelandAtrovent 250 UDVs 250 micrograms/ 1ml Nebuliser SolutionBoehringer Ingelheim International GmbH
- SpainATROVENT MONODOSIS 500 mcg/ 2ml SOLUCION PARA INHALACION POR NEBULIZADORBoehringer Ingelheim Espana S.A.
- NorwayAtroventBoehringer Ingelheim International GmbH
- FinlandAtroventBoehringer Ingelheim International GmbH
- IcelandAtroventBoehringer Ingelheim International GmbH*
Authorised across Europe · EMA
The same active substance is authorised in 26 EEA countries. Names it is sold under:
- Austria · Atrovent - Dosieraerosol, Ipratropiumbromid Infectopharm
- Belgium · Atrovent, Atrovent Hfa
- Cyprus · Atrovent
- Czechia · Atrovent, Atrovent N
- Germany · Atrovent, Atrovent Ls
- Denmark · Atrovent, Ipratropiumbromid Teva
- Estonia · Atrovent N
- Spain · Atroaldo, Atrovent
- Finland · Atrovent, Atrovent Eco
- United Kingdom (Northern Ireland) · Atrovent Inhaler Cfc-Free, Atrovent Udvs
- Greece · Atrovent, Broncovent
- Croatia · Atrovent, Atrovent N
- Hungary · Atrovent N
- Ireland · Atrovent 250 Udvs, Atrovent 500 Udvs
- Iceland · Atrovent, Lomuspray
- Italy · Atem, Nasipral
- Lithuania · Atrovent N
- Luxembourg · Atrovent, Atrovent Hfa
- Malta · Atroaldo, Atrovent Inhaler Cfc-Free
- Netherlands · Atrovent, Atrovent Unit Dose
- Norway · Atrovent, Ipraxa
- Poland · Atrodil, Atrovent
- Portugal · Atrovent, Atrovent Pa
- Romania · Ipravent Inhaler
- Sweden · Atrovent, Ipravent
- Slovakia · Atrovent N
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/30ee6512-b92f-49a1-bc9d-5d5f24c8dfb1 GET /v1/drugs/30ee6512-b92f-49a1-bc9d-5d5f24c8dfb1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "60175716",
"date_amm": "2002-12-20",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "IPRATROPIUM (BROMURE D') MONOHYDRATÉ",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution pour inhalation par nébuliseur",
"voies_administration": "inhalée",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about ipratropium (bromure d') monohydraté.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.